Foot Perfusion by Dynamic Contrast Enhanced MRI in Patients With Peripheral Artery Disease
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorFudan University
About this trial
We investigate the peri-operative foot perfusion through dynamic contrast enhanced MRI in patients with peripheral artery disease
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
18 to 80 years old;
PAD patients with Fontaine grade II-IV or Rutherford grade 2-6 and underwent a successful revascularization;
Patients completed both pre- and post-operative MRI workups;
Patients signed the informed consent form and be able to complete the clinical follow-up for 1 months.
Disqualifiers
Patients has participated in other clinical studies;
Patients with Heart failure (NYHA III/IV)/right to left shunt heart disease/ severe aortic and mitral insufficiency/acute coronary syndrome/malignant arrhythmia/severe pulmonary hypertension (pulmonary artery pressure at least 90 mmHg)/moderate to severe renal insufficiency (creatinine clearance rate<60 ml/min)
Any allergic constitution;
Pregnancy and childbirth;
Trial population
patients with peripheral artery disease, who had a successful endovascular treatment and completed both pre- and post-operative MRI workups
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
DCE MRI
Diagnostic testthe recruited patients should complete pre- and post-operative DCE MRI workshops
Treatment groups
30 Participants
are divided into 1 treatment groupGroup A: PAD group1 intervention
Trial outcomes
Primary outcomes
1
preoperative perfusion parameters
preoperative perfusion parameters by dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI)
Time frame
Between Aug.1 2024 and OCT.31 2024Secondary outcomes
1
ankle brachial index
Time frame
Between Aug.1 2024 and OCT.31 20242
clinical success
Time frame
Between Aug.1 2024 and NOV.30 20243
survival
Time frame
Between Aug.1 2024 and NOV.30 2024Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: